medical treatment of obesity 2016
TRANSCRIPT
Treatment of Obesity
Magnitude of problem 50% of US population is
overweight (BMI > 25) 22% are obese (BMI >
30) Second most common
cause of death in US 60 Billion a year is
spent on diet programs and supplements (2012 figure)
Obesity in America
Everything you know about calories is wrong
Kcal (food calorie)- amount of energy required to heat 1 kg of water by 1 C. Fats- 9 kcal/gram Carbohydrates and proteins-
4 kcal/gram Calculation are from a 19th
century lab experiment
Dunn, R. Scientific American, Sept ‘13
Everything you know about calories is wrong
In reality it depends on- If the food evolved to survive
digestion How cooking affects its structure and
chemistry How much energy the body expends
to break down the food The extent to which the GI flora aids
digestion or steals calories
Everything you know about calories is wrong
Has the food evolved to survive digestion? How durable are the cell walls? Baby
spinach vs. adult spinach. When cell walls hold strong- foods
preserve their calories and pass through our body intact
People who eat almonds received only 128 calories, instead of the 170 that was estimated
Everything you know about calories is wrong
How cooking affects the structure and chemistry Cooking helps to break
down food- making it more easily digestible.
Studies in mice show greater weight gain in mice feed cooked instead of raw sweet potatoes and meat
Everything you know about calories is wrong
How much energy does the body expend to break down the food? Whole wheat bread requires 2x more
energy to digest and only gives 90% of the calories
The extent to which the GI flora aids digestion or steals calories Lactase is the classic example- high
calorie latte or low calorie diarrhea?
Morbid Conditions Related to Obesity
Venous stasis Atherosclerosis Diabetes Dysmenorrhea Reflux Hirsutism Hypertension
Osteoarthritis Sleep apnea Restrictive lung
disease Depression Cancer (endometrial,
colon, prostate, and breast)
Clinical Evaluation of Obese Adults
Eckel R. Nonsurgical Management of Obesity in Adults. NEJM. 2008;358:1941-50.
Treatment options
1. Diet and exercise
2. Medical3. Surgery
Guidelines from National Heart, Lung, and Blood Institute
Effectiveness of diet 29% of US men
and 44% of women report trying to lose weight.
Only 20% of those people report decreasing calories
Nonpharmacologic weight loss
Adding exercise to caloric restriction minimally improves initial weight loss. But is the component that most likely
contributes to long-term maintenance of decreased weight
Exercise is one the most evidence-based intervention that people can do to improve their health.
Which “diet” is best? Low-Fat Diet
Ornish diet (<7% fat) has been shown to decrease progression of atherosclerosis
Low-Carbohydrate Diet Significant better weight loss at 6 months More effective for weight loss and cardiovascular risk reduction
Mediterranean Diet 25% reduction in death from cancer and heart disease, also
decreases dementia. Vegan Diet
Improves glycemic control and LDL
Weight loss companies
LA Weight loss Jenny Craig Nutrisystem Weight
Watchers Dr. Gann’s Diet
of Hope
Electronic programs to help weight loss Cochrane Review 2012
Meta-analysis of 14 weight loss studies with 2537 people
People who used on-line programs lost 1.5 kg more than the control group
However, those enrolled in face-to-face programs lost 2.1 kg more
Feedback is important
Electronic programs Lose It! 40-30-30 Calorie Tracker iMapMyRun BuddySlim.com FatSecret.com MyFoodDiary.com
Obesity: Medical Therapy Three mechanisms of obesity medication.
1. Decrease food intake by reducing appetite or increasing satiety.
2. Decrease absorption3. Increase energy expenditure
– No medications in US approved that act by this method (e.g. ephedrine).
Obesity: Medical therapy Xenical/orlistat/Alli Belviq/locaserin Contrave/
bupropion-naltrexone
Qsymia/phentermine-topiramate
Saxenda/liraglutide
Appetite-suppressant medications
Noradrenergic agents Phentermine: approved for short-term weight loss
(<12 weeks)Monotherapy has not been
associated with valvular disease (compared to combination therapy with Fenfluramine)
Phenylpropanolamine: was approved for OTC appetite suppressant, but was withdrawn due to risk of hemorrhagic stroke
Appetite-suppressant Medications
Lorcaserin- Selective serotonin 2C receptor agonist (Belviq)
Increases weight loss from 2.2 kg to 5.8 kg compared with placebo
Weight returned to baseline after medication was stopped.
Approved by FDA July ‘12
Locaserin effectiveness
Smith et. al. in NEJM 2010;363:245-56.
Medication that reduces absorption
Orlistat (Xenical): binds GI lipases preventing hydrolysis of dietary fats. Excrete in the stool about 1/3 of fat calories Pt’s lose 9% of body weight, compared to 5% with
placebo Associated with decreased blood pressure and
fasting insulin level Pt’s should take daily vitamins Once medication is stopped, weight is regained. ½ strength dose available OTC as Alli
Phentermine/topiramate (Qsymia)
Combination medicine approved July 2012 Phentermine- reduces appetite and decreases
oral intake Topiramate- appetite suppressant and satiety
enhancement Given daily in the morning due to insomnia
Start 3.75/23mg daily for 14 days, than titrate to 7.5/46mg daily and evaluate in 12 weeks
If less than 3% weight loss – either stop of increase dose to 11.25/69 for 14 days, than 15/92mg daily
Recheck in 12 weeks and if less than 5% weight loss- stop drug
Phentermine/topiramate
Phentermine/topiramate (Qsymia)
Phentermine/topiramate (Qsymia)
Significant improvement with treatment Blood pressure, lipid
concentration, and blood glucose levels
Risks include Nephrolithiasis,
hypokalemia, dry mouth, paresthesia, constipation and insomnia
Bupriopion/Naltrexone (Contrave)
Combination medicine approved Sept 10th 2014 Initially rejected in 2011 due to concern of cardiac problems Approved for adults with BMI > 30 or >27 and one weight-
related condition In conjunction with weight loss program
Evaluate at 12 weeks and drug should be stopped if there is not >5% weight loss
Patients lose 4% more of bodyweight with medicine compared to placebo (9% compared to 5%).
Nausea in 34% of patients- patients should be warned about suicide risk
May raise blood pressure
Saxenda/Liraglutide Better known as
Victoza 3.0 mg dose-
compared to 1.2 or 1.8 for diabetes
Patients lost 8% of body weight compared to 2.6% with placebo.
Saxenda/liraglutide
Saxenda/liraglutide
HCG First suggested as treatment for obesity in 1954 Lancet
paper Obtained from the urine of pregnant women Popular in 1970’s Multiple clinical trials show no benefit Current popularity due in part to Kevin Trudeau’s 2007
book “The weight loss cure they don’t want you to know about.” “Miracle weight loss breakthrough” FTC ordered Trudeau to pay $37 million
HCG American Society of Bariatric Physicians (2009)
Numerous clinical trials have shown HCG to be ineffectual in producing weight loss. HCG injections can induce a slight increase in muscle mass in androgen-deficient males. The diet used in the Simeons method provides a lower protein intake than is advisable in view of current knowledge and practice. There are few medical literature reports favorable to the Simeons method; the overwhelming majority of medical reports are critical of it. Physicians employing either the HCG or the diet recommended by Simeons may expose themselves to criticism from other physicians, from insurers, or from government bodies.
Bariatric Surgery: types Gastric
restriction Gastric
resection with bypass
Gastric resection with malabsorption
Other
Gastric restriction (AKA gastroplasty)
Decreases stomach capacity
Food distends pouch causing satiety
Several main methodsBoth decrease
stomach contests to 10-20 cc
Vertical-banded gastroplasty
Gastric restriction: adjustable gastric banding
Most common bariatric procedure in Australia and Europe
Adjustable banding is associated with a decreased rate of weight loss compared to vertical-banded.
Gastric restriction with bypass Used to be the most
common bariatric procedure in US
Length of Roux limb varies between 75-150 cm Longer for more
weight loss Results in more
weight loss then gastric restriction
Gastric resection with malabsorption Two types of surgery Original procedure
Hemigastrectomy Biliopancreatic limb of the
bypass is attached to ilium 50cm from ileocecal valve
High incidence of malnutrition and vitamin deficiencies.
Gastric resection with malabsorption
Modification of bypass- biliopancreatic bypass with duodenal switch Increases common loop to
100cm Less side effects Calcium deficiency still occurs
AspireAssist A modified 6 mm PEG
tube Allows patients to remove
up to 30% of stomach contents after a very well masticated meal
Costs about $10,000 Device stops working
after 6 weeks, tube must be shortened as people lose weight
AspireAssist
AspireAssist
Coolsculpting FDA approved fat-
reduction treatment Cold can cause fat cells
to undergo apoptosis without damaging other tissue AKA cryolipolysis
Best for people who has lost weight already
Coolsculpting
Complications of Surgery
Complications: Dumping In gastric bypass,
patients are unable to tolerated food high in fat and sugar
Postprandial diaphoresis, weakness and malaise
Symptoms usually improve
Complications: Nutritional deficiencies ALL surgery pt’s
are at risk 2/3 of patients have
hyperhomocystemia Risk of deficiency
depends on operation Roux: iron, vitamin
B12 or calcium Bypass: calorie and
fat soluble vitamin
Iron deficient anemia
One of most frequent deficiencies after surgery Incidence after VBG is about 1/3 Incidence after bypass is about ½ Absorption of iron
Ferric ion must be reduced to ferrous state to be absorbed by stomach acid.
Production of stomach acid is significantly decreased after surgery
Other vitamins
Vitamin B12: requires intrinsic factor to be absorbed Because a large amount of B12 is stored in the
liver, usually takes 1-9 years for patients to show def.
Thiamine: absorbed in the entire duodenum Calcium/Vit D: calcium is mainly absorbed in
duodenum and proximal jejunum
Complications: Reflux Seen in vertical banding
gastroplasty 5-fold increase in reflux
Can be treated with gastric bypass
Complications: Osteoporosis Decreased density
observed Unclear mechanism,
not due to hyperparathyroidism At risk for calcium
and vit D deficiency Clinical significance
not established.Intern R2 R3
Complications: Gallstones Rapid reduction of
weight is associated with gallstones
27% of bariatric surgery pt’s require cholecystectomy in 3 years Prophylactic
cholecystectomy? Ursodilol 600 mg daily
Other complications
Gastrogastric fistula Ulcer/stricture Excess skin
Most surgeons will wait to remove skin until 1 year at a stable weight
Bariatric surgery: How well does it work?
Sjostrom et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 years after Bariatric Surgery. NEJM. 2004;351:2683-2693.
Swedish Obese Subjects (SOS) Study
Prospective, cohort trial involving 4047 obese pt’s.
Surgery pt’s were matched 5 months before surgery with control Considered 18 variables when matching
Treatment was surgery or usual care Surgeries: Fixed or variable banding, vertical
banding, or gastric bypass
Sjostrom L et al. N Engl J Med 2007;357:741-752
Results
Sjostrom L et al. N Engl J Med 2007;357:741-752
SOS adverse events
0.25% died post-op 13% had post-op complications
6.1% pulmonary 2.1% deep infections 1.5% wound complication 0.8% PE/DVT 0.5% bleeding complications
Health care use during 20 years following surgery Followed SOS subjects- 2010 adults who
underwent surgery and 2037 matched controls Compared to controls
Bariatric surgery patients used more inpatient and nonprimary outpatient care during the first 6 year period, but not thereafter
Drug costs from years 7-20 were lower for surgery patients than controls
Neovius et. al. JAMA. 2012;308(11):1132-1141
Obesity: the future Pharmaceutical
companies are investing significant resources into treating obesity
Lesson from schizophrenia, GERD and most other diseases
Is obesity an addiction?
Studies in obese rats show similar behavior to drug addicted rats- behavior persists despite negative consequences.
Endorphin blocking drugs decrease overeating as well as heroin, alcohol and cocaine use
Lorcaserin stimulates serotonin receptor which also reduces the desire to consume nicotine in lab rats